Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer

This will be a randomized phase II clinical trial of patients with histologic documentation of metastatic colorectal cancer, who have received local and currently approved standard therapies, excluding RGF.

本研究为一项针对经组织学证实的转移性结直肠癌患者的随机II期临床试验，入组患者均已接受局部治疗及当前获批的标准治疗方案，且排除RGF。